Search the Newsreel

Altria Group, Inc. (MO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Altria Group, Inc. (MO) after the company reported second-quarter 2026 financial results below expectations and lowered its full-year guidance. The investigation focuses on whether Altria adequately disclosed risks related to its smoke-free product strategy …

Altria Group (MO) Securities Investigation Notice - Levi & Korsinsky

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Altria Group (NYSE: MO) shareholders lost money on July 30, 2026 when the stock fell sharply after the Company reported second-quarter results that came in below Wall Street consensus on both earnings and revenue, and then …

Altria's Premium Cigarette Exposure Leaves It Vulnerable to Tradedown but Can Keep Raising Prices

Altria, the dominant cigarette maker in the US, faces vulnerability due to its premium cigarette exposure, which could lead to downtrading by consumers. Despite this risk, the company retains the ability to continue raising prices. Its Marlboro brand commands a significant 40% market share, …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Altria Group, Inc. (MO) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Altria Group, Inc. (MO) after the company missed Q2 2026 financial expectations and lowered its full-year earnings guidance. The investigation focuses on whether Altria adequately disclosed regulatory and financial risks related to its smoke-free …

Altria Group Inc (MO) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Altria Group Inc (MO), detailing its current price momentum score, support and resistance levels, and the readings from various technical indicators. It also includes information on moving averages and addresses frequently asked questions about technical ratings and …

Altria Group, Inc. $MO Shares Bought by Czech National Bank

Czech National Bank increased its stake in Altria Group, Inc. by 4% in the second quarter, bringing its total holdings to 475,315 shares valued at $34.2 million. Institutional investors now own 57.41% of Altria, which has an average analyst rating of "Hold" and a …

Janus Henderson Group PLC Sells 88,703 Shares of Altria Group, Inc. $MO

Janus Henderson Group PLC reduced its stake in Altria Group, Inc. (NYSE:MO) by 53.9% in the first quarter, selling 88,703 shares and retaining 76,002 shares valued at $5.02 million. Altria reported quarterly revenue of $5.36 billion but missed EPS estimates at $1.48, though it …

Assenagon Asset Management S.A. Buys 3,511,430 Shares of Altria Group, Inc. $MO

Assenagon Asset Management S.A. significantly increased its stake in Altria Group, Inc. by 3,691.2% during the second quarter, acquiring an additional 3,511,430 shares. The firm now owns 3,606,561 shares of Altria, valued at approximately $259.5 million, representing 0.22% of the company. Despite recent insider …

Altria Group (NYSE:MO) Stock Price Down 1.2% - What's Next?

Altria Group (NYSE:MO) saw its stock price drop by 1.2% to $67.64, with trading volume 11% higher than average. Analysts maintain a "Hold" rating for the company, with a consensus price target of $70.78. Despite missing EPS estimates slightly, Altria's revenue narrowly beat expectations …

Is Wall Street Bullish or Bearish on Altria Group Stock?

Altria office sign in Virginia capital city tobacco business closeup By Kristina Blokhin Richmond, Virginia-based Altria Group, Inc. (MO), with a market capitalization of approximately $113.7 billion, is a leading U.S. tobacco company that manufactures and markets cigarettes, cigars, smokeless tobacco, oral nicotine pouches, …

The Top 5 Analyst Questions From Altria’s Q2 Earnings Call

Projeções de Resultados: Altria Group Inc (MO) — LPA e Crescimento de Receita

Bronstein, Gewirtz & Grossman, LLC Is Investigating Altria Group, Inc. (MO) And Encourages Stockholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Altria Group, Inc. (MO) after the company missed Q2 2026 earnings and revenue expectations and lowered its full-year guidance. The investigation focuses on whether Altria adequately disclosed risks related to its smoke-free product strategy …

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Altria Group (MO)

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Altria Group (NYSE: MO) shareholders lost money on July 30, 2026 when the stock fell sharply after the Company reported second-quarter results that came in below Wall Street consensus on both earnings and revenue, and then …

Altria Group expands On! Plus distribution

Altria Group's oral nicotine company, Helix Innovations, has significantly expanded the distribution of its On! Plus nicotine pouches to 120,000 stores nationwide. This expansion follows FDA marketing approval for six varieties in late 2025. The company also reported a 5.1% year-over-year increase in On! …

MO SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Altria Group

SueWallSt is notifying investors of a potential securities claims investigation involving Altria Group (NYSE: MO). This comes after Altria reaffirmed its full-year 2026 adjusted diluted EPS guidance in April 2026, then subsequently cut its outlook in July 2026, causing a stock decline. The investigation …

Altria Group, Inc. (MO) Stock forecasts

Morningstar's analyst report indicates that Altria's earnings are being negatively impacted by downtrading in combustibles and disappointing performance from its On! product. Despite these challenges, Altria, through its subsidiaries like Philip Morris USA and U.S. Smokeless Tobacco, maintains a dominant position in the U.S. …

Altria Group (MO) Faces Investigation Over On! PLUS FDA Disclosure Claims

Altria Group (MO) is under investigation by Levi & Korsinsky regarding disclosures related to the FDA regulatory status of its on! PLUS nicotine pouch product. The probe focuses on whether Altria accurately communicated the near-term FDA authorization prospects for the product, adding a new …

Amundi Purchases 104,225 Shares of Altria Group, Inc. $MO

Amundi increased its stake in Altria Group, Inc. (NYSE:MO) by 10.1% in the first quarter, acquiring an additional 104,225 shares. This purchase brings their total holding to 1.14 million shares, valued at approximately $75.2 million. Despite a Q2 revenue increase, Altria missed adjusted EPS …

Edgestream Partners L.P. Cuts Stock Holdings in Altria Group, Inc. $MO

Edgestream Partners L.P. significantly reduced its stake in Altria Group (NYSE:MO) by 60% in the first quarter, selling 82,807 shares and retaining 55,135 shares. Despite this, other institutional investors like Vanguard Group and State Street Corp increased their holdings. Altria reported slightly better-than-expected revenue …

Altria Among 7 Dividend Kings To Announce Annual Dividend Increases In August

Altria Group is projected to announce its 56th consecutive annual dividend increase in August, with an expected boost of 3.7–4.7% to $4.40–$4.44, resulting in a predicted forward yield of 6.44–6.50%. The company continues its shift towards non-tobacco nicotine products, aiming for mid-single-digit EPS and …

Vestor Capital LLC Lowers Stock Position in Altria Group, Inc. $MO

Vestor Capital LLC significantly reduced its stake in Altria Group, Inc. by 98.9% in the first quarter, selling over 500,000 shares. This move comes as Altria reported a 1.2% year-over-year revenue increase and a slight rise in adjusted EPS but missed analyst estimates and …

Altria Group, Inc. $MO Shares Sold by South Dakota Investment Council

South Dakota Investment Council significantly reduced its stake in Altria Group (NYSE:MO) by 74% in the first quarter, selling 53,800 shares. Despite this, other major institutional investors increased their holdings, and Altria maintains a consensus "Hold" rating from analysts with a substantial 6.2% dividend …

Altria (MO) Stock Faces Smoke Free Doubts Despite Higher Profit Outlook

MO Q2 Deep Dive: Margin Pressure Amid Consumer Strain and Smoke-Free Investments

MO Q2 Deep Dive: Margin Pressure Amid Consumer Strain and Smoke-Free Investments Tobacco company Altria (NYSE:MO) met Wall Street's revenue expectations in Q2 CY2026, with sales up 1.2% year on year to $5.36 billion. Its non-GAAP profit of $1.48 per share was 1.2% below …

Altria Group Q2 Earnings Call Highlights

Altria Group reported higher adjusted earnings for Q2 2026, driven by pricing in its smokable-products segment and growth in its nicotine pouch portfolio. The company raised its full-year adjusted EPS guidance to $5.61–$5.72, despite declining cigarette volumes due to consumers shifting to discount products. …

Altria Continues to Focus on Smoke-Free Products

Altria Group Inc. reported its second-quarter and first-half 2026 business results, emphasizing its continued focus on expanding its smoke-free product portfolio, such as on! PLUS, and strengthening its traditional tobacco businesses. The company narrowed its full-year earnings guidance, expecting adjusted diluted EPS growth between …

Altria Stock Trades Below The Market On Earnings And Above It On Sales

Altria Group (NYSE:MO) Issues Earnings Results

Altria Group (NYSE:MO) reported Q2 adjusted EPS of $1.48, missing analyst estimates of $1.50, but revenue rose 1.2% year-over-year to $5.36 billion, slightly exceeding expectations. The company modestly improved its 2026 outlook and returned nearly $3.9 billion to shareholders, however, challenges like inflation-driven trade-down …

Altria Group Inc (MO) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and On+ Expansion ...

This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Altria Group Inc (NYSE:MO) delivered strong first half results with adjusted diluted EPS growth of …

Altria signals 2026 adjusted diluted EPS of $5.61 to $5.72 while planning on! PLUS 12 mg national expansion in Q3

Earnings Call Insights: Altria Group, Inc. (MO) Q2 2026 MANAGEMENT VIEW * "In the second quarter, our operating companies continue to deliver against the priorities we outlined at the start of the year, advancing our smoke-free portfolio, strengthening our traditional tobacco businesses and delivering …

Altria misses quarterly profit estimates as premium cigarette demand weakens

Altria Group missed its second-quarter earnings estimates due to weakening demand for its premium cigarettes and nicotine pouches, triggered by macroeconomic uncertainty and higher living costs. While discount cigarette volumes jumped, shipment volumes for its Marlboro brand and On! nicotine pouches declined, and its …

Altria Group Down Over 9%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Altria Group's stock (MO) is experiencing a significant downturn, dropping over 9% and set for its largest percentage decrease since June 2022. The trading volume is also exceptionally high, surpassing its full-day average. This decline follows a pattern of underperformance compared to the S&P …

Why Altria Stock Is Sinking Today

Altria (NYSE: MO) stock is seeing a pullback on Thursday following the company's latest quarterly report. The tobacco giant's share price was down 9.3% as of 12:25 p.m. ET. At the same point in the day's trading, the S&P 500 index was up 1.3%. …

Altria Group Inc. stock underperforms Thursday when compared to competitors

Altria Group Inc. (MO) shares fell by 9.32% on Thursday, closing at $67.94, despite an overall positive trading day for the stock market, with the S&P 500 and Dow Jones Industrial Average both rising. This decline ended a two-day winning streak for the company's …

Altria Profit Falls on Softer Oral-Tobacco Performance

Altria Group reported a decline in second-quarter profit, falling to $2.3 billion from $2.38 billion a year earlier. This decrease was attributed to softer performance in its oral tobacco segment, specifically lower sales of nicotine pouches, which counteracted growth in its cigarette business. Despite …